LUPUS, cilt.22, sa.13, ss.1416-1424, 2013 (SCI İndekslerine Giren Dergi)
Background Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a variety of clinical features. Survival has become longer as a result of better treatment modalities and better supportive care. There is no information on survival of SLE patients in Turkey. We evaluated clinical features and survival in SLE patients in two rheumatology departments.